Back to Search
THOMAS SUTTER, D.O.
D.O.
Occupational Medicine Physician
NPI: 1972614683Individual
Specialties, Licenses & Credentials
Occupational Medicine PhysicianPrimary
Preventive Medicine — Occupational Medicine
Code: 2083X0100X
036073649(IL)
Research & Publications (20)
Protection against aflatoxin B1-induced cytotoxicity by expression of the cloned aflatoxin B1-aldehyde reductases rat AKR7A1 and human AKR7A3.
PMID 18416522·Chem Res Toxicol·2008
7-preclinical
Analyzing microarray data with transitive directed acyclic graphs.
PMID 19226664·J Bioinform Comput Biol·2009
8-other
Transgenic expression of aflatoxin aldehyde reductase (AKR7A1) modulates aflatoxin B1 metabolism but not hepatic carcinogenesis in the rat.
PMID 19168568·Toxicol Sci·2009
7-preclinical
Genetic versus chemoprotective activation of Nrf2 signaling: overlapping yet distinct gene expression profiles between Keap1 knockout and triterpenoid-treated mice.
PMID 19386581·Carcinogenesis·2009
7-preclinical
Chemical genomics of cancer chemopreventive dithiolethiones.
PMID 19126641·Carcinogenesis·2009
7-preclinical
EGF receptor signaling blocks aryl hydrocarbon receptor-mediated transcription and cell differentiation in human epidermal keratinocytes.
PMID 19255421·Proc Natl Acad Sci U S A·2009
8-other
Microarray analysis reveals distinctive signaling between the bed nucleus of the stria terminalis, nucleus accumbens, and dorsal striatum.
PMID 17911379·Physiol Genomics·2008
4-observational
Quantification of urinary aflatoxin B1 dialdehyde metabolites formed by aflatoxin aldehyde reductase using isotope dilution tandem mass spectrometry.
PMID 18266327·Chem Res Toxicol·2008
7-preclinical
CYP1B1 is not a major determinant of the disposition of aromatase inhibitors in epithelial cells of invasive ductal carcinoma.
PMID 18256205·Drug Metab Dispos·2008
7-preclinical
Toxicogenomic analysis of gender, chemical, and dose effects in livers of TCDD- or aroclor 1254-exposed rats using a multifactor linear model.
PMID 18178546·Toxicol Sci·2008
7-preclinical
Hormonal markers in breast cancer: coexpression, relationship with pathologic characteristics, and risk factor associations in a population-based study.
PMID 17968031·Cancer Res·2007
8-other
Epithelial to mesenchymal transition in human breast epithelial cells transformed by 17beta-estradiol.
PMID 18056439·Cancer Res·2007
8-other
Identification of novel transcriptional networks in response to treatment with the anticarcinogen 3H-1,2-dithiole-3-thione.
PMID 16317079·Physiol Genomics·2006
7-preclinical
Regioselective 2-hydroxylation of 17beta-estradiol by rat cytochrome P4501B1.
PMID 16893557·Toxicol Appl Pharmacol·2006
7-preclinical
Genetic variation of Cytochrome P450 1B1 (CYP1B1) and risk of breast cancer among Polish women.
PMID 16847423·Pharmacogenet Genomics·2006
8-other
Catechol estrogen quinones as initiators of breast and other human cancers: implications for biomarkers of susceptibility and cancer prevention.
PMID 16675129·Biochim Biophys Acta·2006
6-review
Potent protection against aflatoxin-induced tumorigenesis through induction of Nrf2-regulated pathways by the triterpenoid 1-[2-cyano-3-,12-dioxooleana-1,9(11)-dien-28-oyl]imidazole.
PMID 16489057·Cancer Res·2006
7-preclinical
Uncertainties related to the assignment of a toxic equivalency factor for 1,2,3,4,6,7,8,9-octachlorodibenzo-p-dioxin.
PMID 16460856·Regul Toxicol Pharmacol·2006
6-review
3H-1,2-dithiole-3-thione targets nuclear factor kappaB to block expression of inducible nitric-oxide synthase, prevents hypotension, and improves survival in endotoxemic rats.
PMID 16371450·J Pharmacol Exp Ther·2006
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 810 N. ANTHONY DRIVE, OCCUPATIONAL MEDICINE
URBANA, IL 61801 - Phone
- (217) 383-3229
Quick Facts
- NPI
- 1972614683
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile